Inflammatory Bowel Disease Cohort in Nantes
Recruiting
Observational Study
Inflammatory Bowel Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 360 (estimated)
- Sponsor
- Nantes University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients over 18 years of age;
* Patients with an established diagnosis of IBD: CD, UC, unclassified IBD or refractory chronic pouchitis;
* Patients with active disease requiring surgery or endoscopy, whether performed at diagnosis or prior to initiation of new therapy;
* Pati…
Contacts